GROUP ONE TRADING, L.P. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$54,823
+16.6%
612
-2.9%
0.00%
Q3 2022$47,000
+74.1%
630
+53.7%
0.00%
Q2 2022$27,000
-44.9%
410
-47.0%
0.00%
Q1 2022$49,000
-29.0%
774
-40.2%
0.00%
Q4 2021$69,000
+50.0%
1,294
-0.9%
0.00%
-100.0%
Q2 2014$46,000
+360.0%
1,306
+326.8%
0.00%
Q1 2014$10,0003060.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders